I'm not a vascular person or an MS person, but this story in the Globe and Mail irks me. I read the original news article on Saturday, thought it was interesting and was looking forward to how the MS treatments would eventually change. I will note, that as I read the original newspaper article, I noticed there was no mention of the studying being published. I thought this was odd as normally news stories will make a big splash and state which science/medical journal would be publishing the study. I was impressed with the caution and restraint that the not-for-profit MS Societies were showing.
Now it appears that the MS research focus may change and significant dollars will go into what may or may not be a valid research avenue. I say may or may not because I have no experience with MS research, I know nothing of about the validity of the original paper. I have not read it. I do not know what is the basis of the methodology was, what are the peer reviews saying? How was the recovery defined? How long were patients followed?
What I find interesting is that the MS Society is putting money into this avenue, not because it can answer those questions or because a push by the MS research community but because of hype from a investigate news journal and a newspaper.
I'm all for open access to research; a researcher must be able to example to the lay public what is going on. However, I do believe that science policy needs to remain above public opinion. There is a reason why good policy does not make good politics. Good policy can be a bitter pill to swallow. Which is not to say this guy might not be on to something. He may, but the treatment needs to be well studied, repeated etc.
18 hours ago